Chapter 3: Patents and related rights
A potentially very significant change is about to be seen in EU patent law, with the imminent introduction of the unitary patent, and the establishment of the Unified Patent Court. The patent system is regarded as crucial for protecting and fostering research and innovation, and the goal of a single patent within the Union was an obviously attractive one. It was seen as having the potential to simplify patent protection for users, and to reduce costs, thereby making the Union a more attractive market to trade in. Yet in spite of the importance which the EU attaches to patents, efforts (over decades) to create an EU-wide patent had previously proved fruitless. Nevertheless, the perceived importance of the objective for the internal market was such that efforts were maintained. Agreement was finally reached in 2013, and preparations are now well under way, with the expectation that the Unified Patent Court will open in 2017. The success of the venture has yet to be proven, but it certainly represents a step change in the reach and ambition of EU patent law. As things currently stand, the effect of EU law on patent law is minimal. The Biotechnology Directive does regulate one self-contained element of patent law: the patentability of biotechnological inventions. There are Regulations which govern the grant of supplementary protection certificates for medicinal products and for plant protection products.
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.